Impact of the acquisition protocol on the sensitivity to demyelination and axonal loss of clinically feasible DWI

Stefania Oliviero1, Cosimo Del Gratta2

  • 1Department Neurosciences, Imaging, and Clinical Sciences, Institute for Advanced Biomedical Technologies, ITAB, Gabriele D'Annunzio University, Chieti, Italy. stefania.oliviero@hotmail.it.

Magma (New York, N.Y.)
|January 8, 2021
PubMed
Abstract

Related Concept Videos